

Your fight against colorectal
cancer (MSI‑H/dMMR) may
start or continue here
OPDIVO, alone or with YERVOY, is an FDA-approved immunotherapy option to treat advanced colorectal cancer (MSI-H/dMMR)
Your fight against colorectal
cancer (MSI‑H/dMMR) may
start or continue here
OPDIVO, alone or with YERVOY, is an FDA-approved immunotherapy option to treat advanced colorectal cancer (MSI-H/dMMR)
Actor portrayals.
OPDIVO or OPDIVO + YERVOY is not approved
for people younger than 12 years of age.
OPDIVO + YERVOY is a treatment option for certain adults and children 12 years and older who have MSI-H/dMMR colorectal cancer that cannot be removed by surgery or has spread to other parts of the body (metastatic)
If you or a loved one are receiving treatment with either OPDIVO + YERVOY or OPDIVO alone for previously treated colorectal cancer, you can find more information in the Medication Guide or speak to your doctor
OPDIVO will not work for everyone. Individual results may vary.